{"createdAt":"8/2/2020, 2:10:43 PM","timestamp":1596391843896,"Company ID number":"374","DMX_ISSUER_NAME":"Meinian Onehealth Healthcare Holdings Co., Ltd.","DMX_ISSUER_ID":"IID000000002171903","Country of Classification":"CHINA","name":"Meinian Onehealth Healthcare Holdings Co Ltd ","code":"002044","stock_exchange":"Shenzhen Stock Exchange","people":[{"id":"美年大健康产业控股股份有限公司_俞熔","group":"board","name":"俞熔","title":"董事长,董事","isMale":true,"age":"49","degree":"博士","salary":"480.0万","stockAmount":"3983万","description":"俞熔先生,董事,1971年12月14日出生,中国籍,无境外永久居住权。1993年7月毕业于上海交通大学,学士学位;1998年毕业于上海财经大学,硕士学位,中欧国际工商管理学院EMBA06级学员;2012年7月毕业于中国中医科学院,博士学位;1998年7月至今,任上海天亿投资(集团)有限公司董事长;2004年至今,任美年大健康产业(集团)有限公司董事长;2006年至今,任上海天亿资产管理有限公司执行董事;2010年至今上海中卫创业投资管理有限公司总经理兼执行董事;2015年至今,任美年大健康产业控股股份有限公司董事长;2016年2月起至2017年9月,任北京华媒康讯信息技术有限公司董事;2016年5月至今,任深圳雷柏科技股份有限公司董事;2017年9月至今任股份公司董事。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_郭美玲","group":"board","name":"郭美玲","title":"副董事长,董事","isMale":false,"age":"52","degree":"硕士","salary":"0.00","stockAmount":"-","description":"郭美玲女士:1968年10月出生,中国国籍,无境外永久居留权,硕士。郭美玲女士现任美年大健康产业控股股份有限公司副董事长、北京世纪长河科技集团有限公司董事长、中国社会福利基金会理事、北京授渔公益基金会理事长。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_徐可","group":"board","name":"徐可","title":"董事","isMale":true,"age":"49","degree":"硕士","salary":"480.0万","stockAmount":"5352万","description":"徐可先生:1971年5月出生,中国国籍,无境外永久居留权,硕士。现任美年大健康产业控股股份有限公司董事兼总裁。历任沈阳惠丰咨询有限公司董事长、安徽商信信息技术有限公司董事长、总经理、沈阳大健康科技健康管理有限公司(现已更名为“沈阳美年健康科技健康管理有限公司”)首席执行官。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_吴琴伟","group":"board","name":"吴琴伟","title":"董事","isMale":false,"age":"47","degree":"博士","salary":"0.00","stockAmount":"-","description":"吴琴伟女士:1973年2月出生,中国国籍,上海交通大学管理学博士。现任上海国盛资本管理有限公司助理总经理。历任上海海外公司副总裁,上实投资(上海)有限公司助理总裁,上海海外新创投资有限公司总经理,丝芙兰(亚洲)有限公司业务发展总监,上海家化联合股份有限公司投资总监等职务。","lastUpdated":"2019-03-12"},{"id":"美年大健康产业控股股份有限公司_徐宏","group":"board","name":"徐宏","title":"董事","isMale":true,"age":"47","degree":"本科","salary":"0.00","stockAmount":"-","description":"徐宏先生,中国国籍,1973年出生,毕业于复旦大学物理系,拥有理学学士学位,中国注册会计师协会会员。徐宏先生曾就职于普华永道会计师事务所,并于2007年7月成为普华永道合伙人。现任阿里巴巴集团财务副总裁、DSM Grup Danişmanlik Iletişim Ve Satiş Ticaret Anonim Şirketi董事、C2 Capital Partners GP Limited董事、上海逸刻新零售网络科技有限公司董事、联华超市股份有限公司非执行董事、阿里健康信息技术有限公司非执行董事、红星美凯龙家居集团股份有限公司非执行董事、美年大健康产业控股股份有限公司董事、阿里巴巴影业集团有限公司非执行董事以及公司董事。","lastUpdated":"2019-12-26"},{"id":"美年大健康产业控股股份有限公司_曾松柏","group":"board","name":"曾松柏","title":"董事","isMale":true,"age":"54","degree":"硕士","salary":"0.00","stockAmount":"-","description":"曾松柏先生:1966年10月出生,中国国籍,硕士学历。现任蚂蚁金服集团CPO、阿里巴巴合伙人。历任英美烟草公司人力资源管理职务、百威英博中国区人事总监、麦当劳中国区人力资源副总裁。同时担任仁励窝网络科技(上海)有限公司董事。","lastUpdated":"2019-12-26"},{"id":"美年大健康产业控股股份有限公司_朱顺炎","group":"board","name":"朱顺炎","title":"董事","isMale":true,"age":"49","degree":"硕士","salary":"--","stockAmount":"-","description":"朱顺炎先生:1971年3月出生,中国国籍,无境外永久居留权,研究生学历。现任阿里健康CEO兼董事长,阿里巴巴创新事业群总裁。2003年,创办武汉迅彩科技公司,任公司总经理。2007年,加入UC优视创业团队,出任UC优视公司出任高级副总裁,负责UC的市场推广及商业化体系搭建。2014年6月,UC优视整体并入阿里巴巴集团。2016年6月,出任阿里妈妈事业部总裁。阿里妈妈隶属于阿里巴巴集团,是国内领先大数据营销平台,拥有阿里巴巴集团的核心商业数据。2017年4月11日,出任移动事业群总裁,负责移动事业群的整体发展及运营。2017年12月1日,出任阿里大UC事业群总裁,负责大UC事业群的整体发展和运营。2018年12月27日,任阿里大文娱新媒体业务总裁分管UC事业部、阿里音乐及创新业务线。2019年6月18日,任阿里巴巴创新业务事业群总裁。","lastUpdated":"2020-05-22"},{"id":"美年大健康产业控股股份有限公司_刘勇","group":"board","name":"刘勇","title":"独立董事","isMale":true,"age":"53","degree":"硕士","salary":"12.00万","stockAmount":"-","description":"刘勇,男,中国国籍,无境外永久居留权,1967年9月出生,中国注册会计师、中国注册资产评估师、中国注册房地产估价师、经济学学士,工商管理硕士,为苏州市新世纪高级青年专业技术人才,苏州市政府金融办“苏州企业上市融资咨询专家团”专家,苏州市国资委重大决策咨询专家、昆山市人民政府金融发展咨询专家、苏州大学会计专业硕士研究生导师。曾任和现任中核苏阀股份有限公司、苏州新区高新技术产业股份有限公司、美年大健康产业控股集团股份有限公司等多家上市公司的独立董事。2010年至今,任公证天业会计师事务所合伙人。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_葛俊","group":"board","name":"葛俊","title":"独立董事","isMale":true,"age":"48","degree":"本科","salary":"12.00万","stockAmount":"-","description":"葛俊先生:1972年6月出生,中国国籍,无境外永久居留权,本科,厦门大学,物理化学专业理学学士。具有独立董事资格证书。现任美年大健康产业控股股份有限公司独立董事、上海交通大学上海高级金融学院副院长;分众传媒信息技术股份有限公司独立董事;利得科技有限公司董事;上海复医天健医疗服务产业股份有限公司独立董事;旭辉集团股份有限公司独立董事。历任上海市建筑科学研究院助理工程师;中欧国际工商学院行政经理、企业和公共关系部副主任、院办主任、院长助理、基金会秘书长;浦东创新研究院院长。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_刘晓","group":"board","name":"刘晓","title":"独立董事","isMale":true,"age":"39","degree":"硕士","salary":"12.00万","stockAmount":"-","description":"刘晓先生:1981年9月出生,中国国籍,无境外永久居留权,硕士。具有独立董事资格证书。现任美年大健康产业控股股份有限公司独立董事、泰康健康产业基金股权投资执行董事。历任CapgeminiUSLLC高级咨询顾问、德睿医疗咨询(上海)有限公司董事总经理、德勤管理咨询(上海)有限公司副总监及中国医疗行业咨询负责人、泰禾医院管理有限公司副总经理、监事。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_王辉","group":"board","name":"王辉","title":"独立董事","isMale":true,"age":"42","degree":"本科","salary":"12.00万","stockAmount":"-","description":"王辉先生:1978年1月出生,中国国籍,无境外永久居留权,大学本科学历,中国注册会计师、注册税务师、律师以及特许金融分析师。现任上海汉森企业管理咨询有限公司合伙人,上海以诺创业投资有限公司董事。曾任职于安达信(上海)企业管理咨询有限公司以及普华永道管理咨询有限公司。","lastUpdated":"2019-04-03"},{"id":"美年大健康产业控股股份有限公司_边国富","group":"supervisoryCommittee","name":"边国富","title":"监事会主席","isMale":true,"age":"67","degree":"本科","salary":"60.00万","stockAmount":"-","description":"边国富先生:1953年1月出生,中国国籍,无境外永久居留权,本科,毕业于中共中央党校。自2012年3月担任美年大健康产业(集团)有限公司纪委书记、华东区域党委书记,现任美年大健康产业控股股份有限公司党委书记、纪委书记。历任南京军区南京总医院政治委员、党委书记、中国卫生思想政治工作促进会医院文化专业委员会常委、中国城市医院政治工作研究会副会长。","lastUpdated":"2019-05-18"},{"id":"美年大健康产业控股股份有限公司_王晓军","group":"supervisoryCommittee","name":"王晓军","title":"监事","isMale":true,"age":"47","degree":"博士","salary":"0.00","stockAmount":"-","description":"王晓军先生:1973年10月出生,中国国籍,无境外永久居留权,博士,毕业于解放军第三军医大学。现任上海天亿实业控股集团有限公司(以下简称“天亿控股”)副总裁、上海天亿弘方企业管理有限公司总经理。历任解放军白求恩医学院、解放军251医院主任、人民卫生出版社、人卫大厦有限公司总经理等职务。","lastUpdated":"2019-05-18"},{"id":"美年大健康产业控股股份有限公司_崔岚","group":"supervisoryCommittee","name":"崔岚","title":"职工监事","isMale":false,"age":"44","degree":"硕士","salary":"64.00万","stockAmount":"120.8万","description":"崔岚女士:1976年11月出生,中国国籍,无境外永久居留权,硕士。现任美年大健康产业控股股份有限公司职工代表监事、总裁助理、浙江公司总经理,历任美国礼来亚洲公司市场部经理、高级人力资源部经理。","lastUpdated":"2019-05-18"},{"id":"美年大健康产业控股股份有限公司_徐可","group":"manager","name":"徐可","title":"总裁","isMale":true,"age":"49","degree":"硕士","salary":"480.0万","stockAmount":"5352万","description":"徐可先生:1971年5月出生,中国国籍,无境外永久居留权,硕士。现任美年大健康产业控股股份有限公司董事兼总裁。历任沈阳惠丰咨询有限公司董事长、安徽商信信息技术有限公司董事长、总经理、沈阳大健康科技健康管理有限公司(现已更名为“沈阳美年健康科技健康管理有限公司”)首席执行官。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_江维娜","group":"manager","name":"江维娜","title":"董事会秘书,副总裁","isMale":false,"age":"41","degree":"硕士","salary":"--","stockAmount":"-","description":"江维娜女士:1979年11月出生,中国国籍,九三学社成员,无永久境外居留权,上海交通大学医学院临床医疗七年制(法语班)医学硕士,法国斯特拉堡Louis-Pasteur大学医学院AFS,2007年获外科执业医师资格。历任法国斯特拉斯堡Haute-pierre医院普外科外籍医师,上海市瑞金医院普外科医师、国信证券医药行业首席分析师。","lastUpdated":"2020-06-16"},{"id":"美年大健康产业控股股份有限公司_押志高","group":"manager","name":"押志高","title":"高级副总裁,财务总监","isMale":true,"age":"41","degree":"硕士","salary":"--","stockAmount":"-","description":"押志高先生:1979年6月出生,中国国籍,无境外永久居留权,EMBA。2007年至2019年期间在阿里网络担任财务主管、财务经理、高级财务经理、财务总监、银泰商业集团CFO。","lastUpdated":"2020-04-30"},{"id":"美年大健康产业控股股份有限公司_宁毅","group":"manager","name":"宁毅","title":"副总裁","isMale":true,"age":"51","degree":"博士","salary":"120.0万","stockAmount":"-","description":"宁毅先生:1969年12月出生,中国国籍,拥有美国永久居留权,哈佛大学博士。历任北京大学助教;卫生部公务员;华盛顿大学助理研究员;哈佛大学医学院研究人员;美国弗吉尼亚联邦大学医学院终身系列助理教授、博士生导师和博士后导师;葛兰素史克医药研发有限公司流行病学总监和高级学术委员(全球SeniorFellow);GSK清华全球健康中心博士后导师;中关村美年健康产业研究院执行院长。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_韩圣群","group":"manager","name":"韩圣群","title":"高级副总裁","isMale":true,"age":"48","degree":"大专","salary":"116.0万","stockAmount":"-","description":"韩圣群先生:1972年4月出生,中国国籍,无境外永久居留权,大专。现任慈铭健康体检管理集团有限公司联席总裁兼北京公司总经理。历任慈铭健康体检管理集团股份有限公司副总裁兼北京公司总经理、北京慈铭健康管理有限公司业务拓展部总监、大连寰宇药房董事长、总经理、大连司威特药业销售部总监。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_林琳","group":"manager","name":"林琳","title":"高级副总裁","isMale":false,"age":"45","degree":"硕士","salary":"150.0万","stockAmount":"1134万","description":"林琳女士:1975年6月出生,中国国籍,无境外永久居留权,本科,EMBA。现任美年大健康产业控股股份有限公司高级副总裁、COO、北京及北方区域总经理,历任黑龙江省森林工业总局外贸翻译,瑞丰商务总经理。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_李林","group":"manager","name":"李林","title":"高级副总裁","isMale":true,"age":"53","degree":"硕士","salary":"110.0万","stockAmount":"237.2万","description":"李林先生:1967年12月出生,中国国籍,无境外永久居留权,硕士。现任美年大健康产业控股股份有限公司高级副总裁、上海及华东区域总经理,历任天津南华皮革化工有限公司总经理、天津人民农药厂常务副总经理、天津康盟集团副总经理。","lastUpdated":"2018-10-17"},{"id":"美年大健康产业控股股份有限公司_张胜江","group":"manager","name":"张胜江","title":"副总裁","isMale":true,"age":"46","degree":"大专","salary":"120.0万","stockAmount":"118.6万","description":"张胜江先生,1974年11月出生,中国国籍,无境外永久居留权,专科。现任美年大健康产业控股股份有限公司副总裁、IT信息部总经理,历任武汉菲旺软件技术有限责任公司程序员、IT项目经理、IT部门总监、美年大健康IT总监。","lastUpdated":"2018-10-17"}],"companyName":"美年大健康产业控股股份有限公司","province":"江苏省","englishName":"Meinian Onehealth Healthcr Hldngs Co Ltd","industry":"医药生物 — 医疗服务Ⅱ","website":"www.health-100.cn","mainBusiness":"健康体检服务","productsName":["体检服务"],"actualController":"俞熔","actualControllerSharePercentage":"7.15%","registeredCapital":"39.2亿元","employeeAmount":"37173","phone":"86-021-66773289","location":"上海市静安区灵石路697号健康智谷9号楼三楼","chineseDescription":"美年大健康产业控股股份有限公司主营业务为健康体检服务。公司是中国领先的专业健康体检和医疗服务集团，在全国29个省市拥有200余家医疗及体检中心。\n　　美年健康于2015年8月完成借壳上市，被借壳公司名称为江苏三友集团股份有限公司，主营业务为服装OEM、ODM出口业务。","foundedDate":"1991-01-22","goPublicDate":"2005-05-18","companyHistory":"美年大健康产业控股股份有限公司（以下简称“本公司”、“公司”或“本集团”），前身为江苏三友集团股份有限公司（以下简称“江苏三友”），系江苏三友集团有限公司在吸收合并南通三和时装有限公司基础上整体变更设立。本公司成立于1991年1月22日，现总部地址位于江苏南通市人民东路218号。截止2014年12月31日，注册资本及实收资本为人民币22,425.0000万元。\n　　根据本公司2014年度股东大会决议通过的利润分配预案，2015年6月3日，以本公司总股本22,425万股为基数，向全体股东每10股送红股2.40股，本次分红后本公司总股本增加至人民币27,807.0000万元。\n　　根据中国证券监督管理委员会2015年7月20日核准并出具的《关于核准江苏三友集团股份有限公司重大资产重组及向上海天亿投资（集团）有限公司等发行股份购买资产并募集配套资金的批复》（证监许可[2015]1718号），江苏三友集团股份有限公司向美年大健康产业（集团）有限公司（以下简称“美年大健康”）原股东上海天亿投资（集团）有限公司（以下简称“天亿投资”）等24名机构股东及俞熔、徐可等79名自然人股东发行股份购买资产（以下简称“重大资产置换及发行股份购买资产”），截至2015年8月10日止，上述美年大健康原股东均已将股权过户至本公司，本次重大资产置换及发行股份购买资产新增股本人民币91,934.2463万元，增资后本公司总股本增加至人民币119,741.2463万元。\n　　根据上述证监许可[2015]1718号文件核准，本公司募集配套资金非公开发行普通股（A股）的发行数量不超过6,097.5609万股。截至2015年8月25日止，本公司募集配套资金实际已发行人民币普通股1,332.8890万股，增资后本公司总股本增加至人民币121,074.1353万元。\n　　本公司于2016年5月27日召开2015年年度股东大会审议通过了《2015年度利润分配预案》，以公司2015年12月31日总股本1,210,74.1353万股为基数，以资本公积金向全体股东每10股转增10股，合计转增股本121,074.1353万股，转增后公司总股本为242,148.2706万股。上述权益分派已于2016年6月13日实施完毕。公司总股本增加至人民币242,148.2706万元。\n　　截止至2017年10月11日止，本次发行股份购买资产新增股本人民币15,086.2274万元，增资后本公司总股本增加至人民币257,234.4980万元。\n　　本公司统一社会信用代码：91320600608304061J，注册地址：江苏南通市人民东路218号，法定代表人：俞熔。\n　　根据本公司2017年度股东大会决议，2018年5月15日，以本公司总股本260,130.5797万股为基数，以资本公积金向全体股东每10股转增2股，本次转增后本公司总股本增加至人民币312,156.6956万元。\n　　根据本公司2019年度第二次临时股东大会决议及中国证券监督管理委员会出具的《关于核准美年大健康产业控股股份有限公司非公开发行股票的批复》（证监许可[2019]1556号），本公司分别向阿里巴巴（中国）网络技术有限公司发行15,895.7575万股、向博时基金管理有限公司发行1,818.1818万股购买美年大健康产业控股股份有限公司（以下简称“美年健康”）的股权。截至2019年10月28日止，本公司已实际非公开发行人民币普通股17,713.9393万股，增资后本公司总股本增加至人民币391,992.0974万元。收起▲","shareholders":[{"organizationId":"T000193922","holderName":"阿里巴巴(中国)网络技术有限公司","totalShare":"3.68亿","sharePercentage":"9.39%"},{"organizationId":"03148304","holderName":"上海天亿资产管理有限公司","totalShare":"2.36亿","sharePercentage":"6.02%"},{"organizationId":"T000258309","holderName":"北京世纪长河科技集团有限公司","totalShare":"2.23亿","sharePercentage":"5.68%"},{"organizationId":"Q0044F049F","holderName":"上海麒钧投资中心(有限合伙)","totalShare":"2.00亿","sharePercentage":"5.10%"},{"organizationId":"Q01BAF26F7","holderName":"杭州信投信息技术有限公司","totalShare":"1.96亿","sharePercentage":"5.00%"},{"organizationId":"","holderName":"云南国际信托有限公司-云南信托-云起3号集合资金信托计划","totalShare":"1.44亿","sharePercentage":"3.67%"},{"organizationId":"T004281422","holderName":"上海维途投资中心(有限合伙)","totalShare":"1.25亿","sharePercentage":"3.18%"},{"organizationId":"T000125370","holderName":"香港中央结算有限公司","totalShare":"9897.26万","sharePercentage":"2.52%"},{"organizationId":"T000262049","holderName":"上海美馨投资管理有限公司","totalShare":"9169.95万","sharePercentage":"2.34%"},{"organizationId":"","holderName":"全国社保基金一一七组合","totalShare":"8352.00万","sharePercentage":"2.13%"}],"englishDescription":"Meinian Onehealth Healthcare Holdings Co.,Ltd, formerly JIANGSU SANYOU GROUP CO., LTD., is a China-based company principally engaged in the provision of physical examination and medical services. The Company mainly provides physical examination, health consultation, health assessment and medical services. The physical examination services of the Company include routine medical examination, early detection and screening for cancers and physical examination report interpretation. The Company mainly operates its businesses in domestic market.","englishIndustry":"Healthcare Facilities","Price to earnings (ttm)":"--","Price to sales (ttm)":"7.75","Price to book (mrq)":"8.98","Price to cash flow (ttm)":"--","Total debt to equity (mrq)":"102.91","Lt debt to equity (mrq)":"47.25","Return on investment (ttm)":"-12.66","Return on equity (ttm)":"-7.09","Income statement":{"Revenue":"8,525.03","Total revenue":"8,525.03","Cost of revenue, total":"4,790.23","Gross profit":"3,734.80","Selling/general/admin. expenses, total":"2,706.69","Research & development":"41.80","Depreciation/amortization":"44.18","Interest exp.(inc.),net-operating, total":"386.01","Unusual expense (income)":"1,066.35","Other operating expenses, total":"(43.51)","Total operating expense":"8,991.76","Operating income":"(466.74)","Other, net":"(19.01)","Net income before taxes":"(485.75)","Provision for income taxes":"227.99","Net income after taxes":"(713.74)","Minority interest":"(152.74)","Net income before extra. items":"(866.47)","Net income":"(866.47)","Income available to com excl extraord":"(866.47)","Income available to com incl extraord":"(866.47)","Diluted net income":"(866.47)","Diluted weighted average shares":"3,919.92","Diluted eps excluding extraord items":"(0.22)","Dps - common stock primary issue":"0.00","Diluted normalized eps":"(0.04)","Gain (loss) on sale of assets":"(0.29)"},"Balance sheet":{"Cash":"3.42","Cash & equivalents":"4,756.10","Cash and short term investments":"4,759.52","Accounts receivable - trade, net":"2,292.57","Total receivables, net":"3,582.98","Total inventory":"129.62","Prepaid expenses":"219.30","Total current assets":"8,691.42","Property/plant/equipment, total - gross":"3,763.28","Accumulated depreciation, total":"(1,067.05)","Property/plant/equipment, total - net":"2,696.23","Goodwill, net":"4,104.39","Intangibles, net":"163.91","Long term investments":"1,388.84","Note receivable - long term":"828.32","Other long term assets, total":"1,045.52","Total assets":"18,918.62","Accounts payable":"862.96","Accrued expenses":"473.32","Notes payable/short term debt":"2,376.69","Current port. of  lt debt/capital leases":"2,155.69","Other current liabilities, total":"2,114.33","Total current liabilities":"7,982.98","Long term debt":"2,550.54","Total long term debt":"2,550.54","Total debt":"7,082.91","Deferred income tax":"3.96","Minority interest":"838.39","Other liabilities, total":"227.13","Total liabilities":"11,602.99","Common stock, total":"3,919.92","Additional paid-in capital":"2,439.94","Retained earnings (accumulated deficit)":"1,256.21","Treasury stock - common":"(300.06)","Other equity, total":"(0.38)","Total equity":"7,315.63","Total liabilities & shareholders' equity":"18,918.62","Total common shares outstanding":"3,919.92","Tangible book value per share, common eq":"0.78","Other current assets, total":"2.00","Short term investments":"0.13"},"Cash flow":{"Cash receipts":"8,333.68","Cash payments":"(2,506.03)","Cash taxes paid":"(247.49)","Changes in working capital":"(4,320.66)","Cash from operating activities":"1,259.51","Capital expenditures":"(429.14)","Other investing cash flow items, total":"(1,011.25)","Cash from investing activities":"(1,440.39)","Financing cash flow items":"1,617.76","Total cash dividends paid":"(612.92)","Issuance (retirement) of debt, net":"1,481.04","Cash from financing activities":"2,485.88","Foreign exchange effects":"0.78","Net change in cash":"2,305.78"},"keyMetrics":{"Price and Volume":{"Price closing or last bid":"15.39","52 Week High":"17.50","52 Week Low":"10.60","Pricing date":"","10 Day Average Trading Volume":"40.12","Market Capitalization":"60,327.58","52 Week High Date":"","52 Week Low Date":"","3 Month Average Trading Volume":"861.99","Beta":"0.89","1 Day Price Change":"-2.10","13 Week Price Return (Daily)":"34.53","26 Week Price Return (Daily)":"9.38","5 Day Price Return (Daily)":"2.67","52 Week Price Return (Daily)":"30.31","Year To Date Price Return (Daily)":"3.36","Month to Date Price Return (Daily)":"6.80","Price Relative to S&P500 (4 Week)":"-5.83","Price Relative to S&P500 (13 Week)":"5.76","Price Relative to S&P500 (26 Week)":"-14.33","Price Relative to S&P500 (52 Week)":"-11.44","Price Relative to S&P500 (YTD)":"-20.95"},"Per Share Data":{"EPS excl. Extra Items (Annual)":"-0.22","EPS excl. Extra Items (TTM)":"-0.30","EPS Normalized (Annual)":"-0.04","Revenue per Share (Annual)":"2.17","Revenue per Share (TTM)":"1.96","Book Value (Per Share Annual)":"1.87","Book Value (Per Share Quarterly)":"1.71","Tangible Book Value (Per Share Annual)":"0.78","Tangible Book Value (Per Share Quarterly)":"0.62","Cash Per Share (Per Share Annual)":"1.21","Cash Per Share (Per Share Quarterly)":"0.84","Cash Flow (Per Share Annual)":"-0.08","Cash Flow (Per Share TTM)":"--","Dividend (Per Share Annual)":"0.00","Dividends (Per Share TTM)":"0.00","EBITD (Per Share TTM)":"-0.11","EPS Basic excl. Extra Items (Annual)":"-0.22","EPS Basic excl. Extra Items (TTM)":"-0.30","EPS incl. Extra Items (Annual)":"-0.22","EPS incl. Extra Items (TTM)":"-0.30","Free Cash Flow (Per Share TTM)":"-0.03","Dividend (Per Share 5Y)":"0.02"},"Valuation":{"P/E excl. Extra Items (Annual)":"--","P/E excl. Extra Items (TTM)":"--","P/E Normalized (Annual)":"--","Price to sales (Annual)":"7.08","Price to sales (TTM)":"7.75","Price to Tangible Book (Annual)":"19.80","Price to Tangible Book (Quarterly)":"24.79","Price to Free Cash Flow (Per Share Annual)":"277.43","Price to Cash Flow (Per Share TTM)":"--","Price to Free Cash Flow (Per Share TTM)":"--","Price to Book (Annual)":"8.25","Price to Book (Quarterly)":"8.98","P/E Basic excl. Extra Items (TTM)":"--","P/E excl. Extra Items High (TTM)":"127.76","P/E excl. Extra Items Low (TTM)":"56.87","P/E incl. Extra Items (TTM)":"--","Net Debt (Interim)":"3,611.54","Net Debt (Annual)":"2,323.40","Dividend Yield (5Y)":"--","Dividend Yield":"--","Current Dividend Yield (TTM)":"0.00"},"Financial Strength":{"Free Cash Flow (Annual)":"217.45","Current Ratio (Annual)":"1.09","Net Interest coverage (Annual)":"2.55","Long Term Debt/Equity (Annual)":"34.86","Payout Ratio (Annual)":"--","Quick Ratio (Annual)":"1.07","Total Debt/Total Equity (Annual)":"96.82","Current EV/Free Cash Flow (Annual)":"--","Current EV/Free Cash Flow (TTM)":"--","Current Ratio (Quarterly)":"1.09","Long Term Debt/Equity (Quarterly)":"47.25","Quick Ratio (Quarterly)":"1.07","Total Debt/Total Equity (Quarterly)":"102.91","Free Cash Flow (TTM)":"-105.86","Net Interest Coverage (TTM)":"-0.76","Payout Ratio (TTM)":"--"},"Margins":{"Gross Margin (Annual)":"43.81","Gross Margin (TTM)":"41.06","Net Profit Margin % (Annual)":"-8.37","Net Profit Margin (TTM)":"-15.65","Operating Margin (Annual)":"-5.47","Operating Margin (TTM)":"-13.42","Pretax Margin (TTM)":"-13.97","Pretax Margin (Annual)":"-5.70","Operating Margin (5Y)":"8.93","Pretax Margin (5Y)":"8.86","Free Operating Cash Flow/Revenue (5Y)":"4.21","Free Operating Cash Flow/Revenue (TTM)":"-1.36","Gross Margin (5Y)":"46.05","Net Profit Margin (5Y)":"5.64"},"Management Effectiveness":{"Return on Assets (Annual)":"-4.05","Return on Equity (TTM)":"-7.09","Return on Average Equity (Annual)":"-12.48","Return on Average equity (TTM)":"-20.46","Return on Investment (Annual)":"-7.49","Return on Investment (TTM)":"-12.66","Return on Average Assets (5Y)":"3.16","Return on Average Equity (5Y)":"4.73","Return on Investment (5Y)":"5.27","Asset Turnover (Annual)":"0.48","Asset Turnover (TTM)":"0.45","Inventory Turnover (Annual)":"37.41","Inventory Turnover (TTM)":"32.01","Net Income/Employee (Annual)":"-18,667.35","Net Income/Employee (TTM)":"-32,769.48","Receivables Turnover (Annual)":"4.00","Receivables Turnover (TTM)":"3.55","Revenue/Employee (Annual)":"222,966.80","Revenue/Employee (TTM)":"209,328.40"},"Growth":{"Revenue Growth (Quarterly YoY)":"-58.15","Revenue Growth Rate (5Y)":"42.90","EPS Growth (Quarterly YoY)":"-383.16","EPS Growth (TTM YoY)":"-237.74","EPS Growth Rate (5Y)":"--","Dividend Growth Rate (3Y)":"--","Revenue Growth (TTM YoY)":"-8.56","Revenue Growth (Per Share 5Y)":"4.01","Revenue Growth Rate (3Y)":"25.49","EPS Growth Rate (3Y)":"--","Book Value Growth Rate (Per Share 5Y)":"1.00","Tangible Book Value Total Equity CAGR (5Y)":"18.62","Capital Spending growth rate 5 year":"10.73","EBITDA CAGR (5Y)":"43.63","EBITDA Interim CAGR (5Y)":"--","Free Operating Cash Flow CAGR (5Y)":"--","Total Debt CAGR (5Y)":"96.96","Net Profit Margin Growth Rate (5Y)":"--"},"Income Statement":{"Revenue (Annual)":"8,525.03","Revenue (TTM)":"7,781.37","EBITD (Annual)":"1,385.73","EBITD (TTM)":"-449.43","Earnings Before Taxes (Annual)":"-485.75","Earnings Before Taxes (TTM)":"-1,086.86","Net Income to Common (Annual)":"-866.47","Net Income to Common (TTM)":"-1,346.63","Earnings Before Taxes Normalized (Annual)":"580.60","Net Income Available to Common Normalized (Annual)":"-173.35","Diluted Normalized EPS excl. Extra Items (TTM)":"-0.30"}}}